ACETAMINOPHEN
NDC 62207-892, ACETAMINOPHEN, tablet, extended release, from Granules India Limited.
- Product NDC
- 62207-892
- Status
- Listed
- Labeler
- Granules India Limited
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA211544
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62207-892 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ACETAMINOPHEN650 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62207-892-49 | 62207089249 | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (62207-892-49) |
| 62207-892-51 | 62207089251 | 1 BOTTLE in 1 CARTON (62207-892-51) / 10 TABLET, EXTENDED RELEASE in 1 BOTTLE |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 62207-892 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62207-892 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62207-892. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.